Clinical Trial Update: Observational Study - TA- 2025-1

View source ↗

Summary

An observational study TA-2025-1 sponsored by Haag-Streit AG is currently enrolling by invitation for Astigmatism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astigmatism

Snippet

Sponsor: Haag-Streit AG | Conditions: Astigmatism | Status: ENROLLING_BY_INVITATION